Company Catalog

Build your portfolio here

Enter the quantity next to the stocks you need — your portfolio will be created automatically.

Open Portfolio

Quick screener: filter by category and recommendation, review fundamentals, metrics and company profiles.

How the catalog works

Total stocks: 28

Dividend Starter Pack Blue Chips — Buy Growth Leaders Defensive — Low Volatility

Category

Recommendation

Sort

Order

Row limit

Advanced filters: dividends, profile and fundamentals

Portfolio stocks only

Price range

Dividends

Min dividend yield

Max vol20%

Investment style

Horizon

Stock role

Min potential

Max risk

EPS(TTM) ≥ ($)

EPS(TTM) ≤ ($)

Revenue QoQ ≥ (%)

Revenue QoQ ≤ (%)

EPS surprise ≥ (%)

EPS surprise ≤ (%)

Reset

Company	Category	Price	Δ%	Div%	Vol20	EPS(TTM)	QoQ	EPS(SPR)	Style	Horizon	Pot.	Risk	Recommendation
Abbott Laboratories (ABT) ext: ABT.US	Pharma	89.65	+0.58%	2.7%	1.7%	3.60	-2.6%	0.0%	Balanced	Medium	43	70	Sell
AbbVie (ABBV) ext: ABBV.US	Pharma	224.77	-0.08%	3.7%	1.3%	2.04	-9.7%	2.3%	Growth	Medium	58	46	Hold
AstraZeneca (AZN) ext: AZN.US	Pharma	182.28	+1.86%	1.4%	1.5%	6.71	-1.4%	2.4%	Growth	Medium	58	67	Hold
Avadel Pharmaceuticals (AVDL) ext: AVDL.US	Pharma	21.64	0.00%	0.0%	0.2%	0.00	13.7%	-162.5%	Growth	Medium	51	69	Hold
Bausch Health (BHC) ext: BHC.US	Pharma	5.16	+0.19%	0.0%	2.7%	-3.21	-12.3%	-3.7%	Growth	Medium	30	80	Sell
Bayer (BAYRY) ext: BAYRY.US	Pharma	10.42	+2.56%	0.3%	1.8%	-0.53	20.3%	23.4%	Growth	Medium	42	70	Sell
Centessa Pharmaceuticals (CNTA) ext: CNTA.US	Pharma	39.77	+0.20%	0.0%	0.2%	-1.78	0.0%	-36.8%	Growth	Medium	40	69	Sell
Compass Pathways (CMPS) ext: CMPS.US	Pharma	11.41	+3.45%	0.0%	6.1%	-2.15	0.0%	33.3%	Growth	Medium	60	66	Hold
CoreSite (COR) ext: COR.US	Pharma	281.48	+0.09%	0.8%	1.5%	13.12	-8.8%	-1.5%	Growth	Medium	32	75	Sell
Eli Lilly (LLY) ext: LLY.US	Pharma	1160.95	+2.16%	0.6%	1.9%	28.20	2.6%	22.7%	Growth	Long	84	26	Buy
Gilead Sciences (GILD) ext: GILD.US	Pharma	125.87	+3.61%	3.2%	1.5%	7.42	-12.2%	6.3%	Growth	Medium	41	68	Sell
GSK (GSK) ext: GSK	Pharma	52.86	+3.30%	3.5%	1.5%	3.42	-11.5%	6.9%	Growth	Medium	60	45	Hold
Incyte (INCY) ext: INCY.US	Pharma	107.83	+2.32%	0.0%	2.0%	7.30	-15.5%	31.2%	Growth	Medium	77	40	Buy
Johnson & Johnson (JNJ) ext: JNJ.US	Pharma	238.33	-0.07%	2.3%	1.3%	8.67	-2.0%	0.7%	Balanced	Medium	68	40	Buy
Ligand Pharmaceuticals (LGND) ext: LGND.US	Pharma	254.57	+2.55%	0.0%	1.8%	7.84	-13.3%	-11.4%	Growth	Medium	65	62	Hold
Merck (MRK) ext: MRK.US	Pharma	120.78	+1.41%	3.5%	2.1%	3.56	-0.2%	1.5%	Growth	Long	69	40	Buy
Moderna (MRNA) ext: MRNA.US	Pharma	49.64	+7.94%	0.0%	4.5%	-8.15	-42.6%	60.9%	Growth	Medium	30	80	Sell
Novartis (NVS) ext: NVS.US	Pharma	153.92	+3.92%	4.1%	1.3%	7.02	1.4%	2.0%	Growth	Long	65	41	Buy
Novo Nordisk (NVO) ext: NVO.US	Pharma	43.96	+2.69%	4.3%	2.2%	27.45	22.3%	11.1%	Growth	Medium	65	55	Hold
Organon & Co (OGN) ext: OGN.US	Pharma	13.45	+0.52%	0.6%	0.2%	0.95	-3.1%	-14.5%	Growth	Medium	40	68	Hold
Pfizer (PFE) ext: PFE.US	Pharma	26.18	+2.25%	6.6%	1.1%	1.31	-17.7%	3.9%	Growth	Medium	42	63	Sell
Revolution Medicines (RVMD) ext: RVMD.US	Pharma	149.23	+3.50%	0.0%	2.8%	-7.11	0.0%	-25.1%	Growth	Medium	41	71	Sell
Roche (RHHBY) ext: RHHBY.US	Pharma	51.35	+1.84%	3.1%	1.8%	2.73	90.4%	0.0%	Growth	Long	63	40	Buy
Teva Pharmaceutical Industries (TEVA) ext: TEVA.US	Pharma	34.56	+2.92%	0.0%	1.9%	1.37	-15.5%	6.0%	Balanced	Medium	45	70	Sell
Vertex Pharmaceuticals (VRTX) ext: VRTX.US	Pharma	445.04	+2.14%	0.0%	1.6%	17.01	-7.4%	5.4%	Growth	Medium	50	70	Sell
Viatris (VTRS) ext: VTRS.US	Pharma	16.31	+3.42%	3.4%	1.8%	-0.26	-5.0%	7.1%	Balanced	Medium	43	67	Sell
Walgreens (WBA) ext: WBA.US	Pharma	11.98	0.00%	0.0%	0.6%	-7.29	1.0%	44.4%	Growth	Medium	40	69	Sell
West Pharmaceutical Services (WST) ext: WST.US	Pharma	330.34	-0.18%	0.3%	1.8%	7.52	5.0%	26.8%	Growth	Long	74	31	Buy